Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down 0.03% Nasdaq Up 0.36%
Streaming
Ticker Tape: On

Actavis plc (ACT)

-NYSE
198.01 Down 1.37(0.69%) 3:44PM EDT - Nasdaq Real Time Price
Get the big picture on all your investments.
Prev Close:199.38
Open:198.49
Bid:197.94 x 200
Ask:197.99 x 100
1y Target Est:241.27
Beta:0.34
Next Earnings Date:30-Apr-14ACT Earnings announcement
Day's Range:195.42 - 200.88
52wk Range:96.52 - 230.77
Volume:1,190,752
Avg Vol (3m):2,889,440
Market Cap:34.49B
P/E (ttm):N/A
EPS (ttm):-5.27
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ACT

Comparison

Symbol% ChgMkt Cap
ACTDown 0.69%34.49B
MYLDown 0.34%17.50B
NVSUp 0.41%205.63B
TEVAUp 2.06%43.20B

Key Statistics

Forward P/E (1 yr):13.55
P/S (ttm):4.00
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :13.05
Quarterly EPS Est (Mar-14) :3.22
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):0.86

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Actavis plc, an integrated specialty pharmaceutical company, is engaged in the development, manufacture, marketing, sale, and distribution of pharmaceutical products in the Americas, Europe, the Middle East, Africa, Australia, and the Asia Pacific. View More

Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback